4Stewart JT, McKenna WJ. Management of arrhythmias in hypertrophic car- diomyopathy[J].Cardiovasc Drugs Ther, 1994,8 (13) : 95.
5Pocoek SJ, Wang D, Pfeffer KS, et al. Predictocs of mortality and morbid- ity in patients with chronic be'art failure[J]. Eur Heart J,2006,27(21 ) :65 - 75.
6Minners J, Vmadenbos EJ, Yellon DM, et al. Dinitrophenol, cyclostxJrine A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochdrial role in cardioprotection [ J ]. Cardiovasc Res, 2000,47(11) :68 - 73.
7Kantor PF, Lucien A, Kozak R, et al. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxida- tion by inhibiting mitochondrial long-chain-3-ketoacyl conzyme A thiolase [J]. Circ Res,2000,86(19) :580 - 588.
二级参考文献25
1[1]Seidman, J.G. and Seidman, C. (2001) The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104, 557-567
2[2]Thierfelder, L. et al. (1994) a-tropomyosin and cardiac troponin Tmutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77, 701-712
3[3]Watkins, H. et al. (1992) Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. New Engl. J. Med. 326, 1108-1114
4[4]Anan, R. et al. (1994) Prognostic implications of novel b cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J. Clin. Invest. 93, 280-285
5[5]Watkins, H. et al. (1995) Mutations in the genes for cardiac troponin T and a -tropomyosin in hypertrophic cardiomyopathy. New Engl. J. Med. 332, 1058-1064
6[6]Moolman, J.C. et al. (1997) Sudden death due to troponin T mutations. J. Am. Coll. Cardiol. 29, 549-555
7[7]Niimura, H. et al. (1998) Mutations in the gene for cardiac myosinbinding protein C and late -onset familial hypertrophic cardiomyopathy. New Engl. J. Med. 338, 1248-1257
8[8]Charron, P. et al. (1998) Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosinbinding protein C gene. Circulation 97, 2230-2236
9[9]Braunwald, E. (2002) Heart Disease; a Textbook of Cardiovascular Medicine, W. B. Saunders
10[10]Lankford, E.B. et al. (1995) Abnormal contractile properties of muscle fibers expressing b-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J.Clin. Invest. 95, 1409-1414
